Zopiclone, sleep and health‐related quality of life
Authors:
- F. GoldenbergFGF. Goldenberg
- M. Le GalMGM. Le Gal
- M. PartinenMPM. Partinen
- 1 July 1994
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 9 (4) , 245-251
Abstract
458 insomniac patients participated in a multinational, randomised, double blind, parallel groups study of zopiclone 7.5 mg versus placebo. Patients received the drug or placebo nightly for 14 days and for a further six weeks on demand. Sleep characteristics and Quality of Life measures were assessed at 14, 28 and 56 days after admission. Both groups of patients improved on these measures, but the active treatment showed significantly greater improvement compared to placebo, both after 14 days and at the end of the trial.Keywords
This publication has 7 references indexed in Scilit:
- Quality of Life and Antihypertensive Therapy in Men -- A Comparison of Captopril with EnalaprilNew England Journal of Medicine, 1993
- ZopicloneDrugs & Aging, 1993
- Joint pain and quality of life; results of a randomised trial.British Journal of Clinical Pharmacology, 1989
- A scale for the estimation of sleep problems in clinical researchJournal of Clinical Epidemiology, 1988
- Zopiclone and Nitrazepam: A Multicenter Placebo Controlled Comparative Study of Efficacy and Tolerance in Insomniac Patients in General PracticeSLEEP, 1987
- Rational Basis for the Use of Sleeping PillsPharmacology, 1983
- The leeds sleep evaluation questionnaire in psychopharmacological investigations?a reviewPsychopharmacology, 1980